Home-grown cervical cancer jab
0 Comments

New Delhi: In a landmark achievement in India’s medical science, the first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer is being launched in the capital today (September 1, 2022). The Drugs Controller General of India (DCGI) had last month granted market authorisation to the Serum Institute of India (SII) to manufacture an indigenously-developed vaccine against cervical cancer.

Author

mukeshathavale.manzi@gmail.com

Leave a Reply

Your email address will not be published. Required fields are marked *